Shielding programme ends for the most vulnerable
Following expert clinical advice, the government is ending the requirement [...]
Cellular signatures of kidney tumours
The origins of seven types of kidney cancer, including several [...]
Overcoming misinformation in the diagnosis and treatment of kidney cancer
In this video interview from UroToday Dena Battle from KCCure, [...]
EIKCS 2021: Future treatments for metastatic kidney cancer
Despite the advances in first-line treatments for metastatic renal cell [...]
UK regulator confirms benefits of AstraZeneca vaccine far outweigh the risks
Following suspensions by some countries of the COVID-19 Oxford AstraZeneca [...]
One Cancer Voice: Plotting a route out of the pandemic and towards world-leading cancer services
Governments across the UK have bold ambitions to improve cancer [...]
HIF-2α inhibitor belzutifan to be fast-tracked for approval for VHL kidney cancer
Kidney cancers frequently have mutations in a gene called the [...]
Nivolumab/cabozantinib combination recommended for EMA approval for first-line kidney cancer
The Committee for Medicinal Products for Human Use (CHMP) of [...]
Warning over COVID-19 cons
The NHS has teamed up with the police and security [...]
Past COVID-19 infection provides some immunity but people may still transmit the virus
A Public Health England (PHE) study (SIREN) finds past infection [...]
